Overview

Mesenchymal Stem Cells in Critical Limb Ischemia

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This clinical trial aims to study the safety and efficacy of adult mesenchymal stem cells in critical limb ischemia.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Stempeutics Research Pvt Ltd
Treatments:
Plasma-lyte 148